IRADIMED CORP - Common Stock (IRMD)

Historical Holders from Q3 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
IRMD on Nasdaq
Shares outstanding
12,733,410
Price per share
$97.28
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
6,912,935
Total reported value
$491,933,058
% of total 13F portfolios
0%
Share change
-109,776
Value change
-$6,192,577
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
183
Price from insider filings
$99.48
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of IRADIMED CORP - Common Stock (IRMD) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nine Ten Capital Management LLC 7.1% $48,648,226 905,926 Nine Ten Capital Management 31 Dec 2024
BlackRock, Inc. 3.9% $26,667,581 496,603 BlackRock, Inc. 31 Mar 2025
As of 30 Sep 2025, IRADIMED CORP - Common Stock (IRMD) has 183 institutional shareholders filing 13F forms. They hold 6,912,935 shares of 12,733,410 outstanding shares (54%) .

Top 25 institutional shareholders own 43% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
BlackRock, Inc. 8% 1,015,876 +5.6% 0% $72,289,752
Nine Ten Capital Management LLC 6.1% 771,384 -12% 14% $54,892,000
VANGUARD GROUP INC 4.4% 566,507 +0.98% 0% $40,312,639
RENAISSANCE TECHNOLOGIES LLC 3.8% 488,762 -0.62% 0.05% $34,780,304
Copeland Capital Management, LLC 3.4% 433,500 -5.3% 0.64% $30,847,919
GEODE CAPITAL MANAGEMENT, LLC 2.1% 266,339 +1.9% 0% $18,954,603
DIMENSIONAL FUND ADVISORS LP 1.7% 214,551 -0.41% 0% $15,266,386
STATE STREET CORP 1.5% 187,239 +5.6% 0% $13,323,927
GOLDMAN SACHS GROUP INC 1.2% 149,801 +4.2% 0% $10,659,839
ACADIAN ASSET MANAGEMENT LLC 1.1% 145,278 -5.8% 0.02% $10,334,000
NORTHERN TRUST CORP 1.1% 137,499 -4% 0% $9,784,429
MORGAN STANLEY 1% 127,202 +39% 0% $9,051,770
Ranger Investment Management, L.P. 0.94% 119,620 -44% 0.59% $8,512,159
Russell Investments Group, Ltd. 0.81% 103,594 -30% 0.01% $7,371,804
Bank of New York Mellon Corp 0.81% 103,232 -0.53% 0% $7,346,022
MILLENNIUM MANAGEMENT LLC 0.77% 98,184 -12% 0.01% $6,986,773
Uniplan Investment Counsel, Inc. 0.61% 77,314 -3.8% 0.54% $5,501,730
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.54% 68,488 +1.8% 0% $4,873,606
ENVESTNET ASSET MANAGEMENT INC 0.53% 67,020 -0.12% 0% $4,769,131
SHAKER INVESTMENTS LLC/OH 0.5% 63,199 +19% 1.8% $4,497,241
Bridge City Capital, LLC 0.47% 59,345 -1.4% 1.1% $4,222,990
ISTHMUS PARTNERS, LLC 0.46% 58,740 +2.4% 0.93% $4,179,938
Qube Research & Technologies Ltd 0.45% 56,826 +17% 0.01% $4,043,738
TWO SIGMA INVESTMENTS, LP 0.42% 53,647 +33% 0.01% $3,817,521
ALGERT GLOBAL LLC 0.4% 50,797 +88% 0.06% $3,615,000

Institutional Holders of IRADIMED CORP - Common Stock (IRMD) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q4 70,708 $6,878,838 +$3,217,318 9,728.27% 6
2025 Q3 6,912,935 $491,933,058 -$6,192,577 7,116% 183
2025 Q2 7,049,520 $421,491,084 +$6,336,536 5,979% 160
2025 Q1 6,961,071 $365,301,337 -$580,349 5,248% 167
2024 Q4 6,970,032 $383,359,036 +$9,147,980 5,500% 166
2024 Q3 6,774,947 $340,330,934 -$4,474,758 5,029% 144
2024 Q2 6,822,202 $299,786,808 +$3,892,743 4,394% 137
2024 Q1 6,716,470 $295,435,220 +$14,779,015 4,399% 125
2023 Q4 6,459,357 $306,655,798 +$17,489,557 4,747% 117
2023 Q3 6,101,541 $270,676,624 -$3,589,822 4,437% 113
2023 Q2 6,133,726 $292,922,488 +$17,028,601 4,774% 109
2023 Q1 5,780,603 $227,464,394 +$10,412,240 3,935% 90
2022 Q4 5,525,882 $156,321,831 -$3,249,669 2,829% 74
2022 Q3 5,606,466 $168,465,363 +$3,059,725 3,006% 81
2022 Q2 5,523,842 $187,480,258 +$1,615,681 3,393.96% 89
2022 Q1 5,372,509 $240,988,874 +$16,505,748 4,484.08% 101
2021 Q4 4,999,149 $230,849,125 +$7,127,231 4,620.74% 95
2021 Q3 4,725,811 $158,784,781 -$1,638,874 3,358.99% 71
2021 Q2 4,763,037 $140,116,293 +$1,376,586 2,940.85% 58
2021 Q1 4,729,017 $122,230,018 +$965,764 2,577.01% 52
2020 Q4 4,699,928 $107,178,220 +$4,636,145 2,279.79% 54
2020 Q3 4,517,233 $96,756,082 -$243,528 2,137.98% 61
2020 Q2 4,511,673 $104,727,212 +$10,282,835 2,320.97% 64
2020 Q1 4,085,698 $87,134,189 +$8,149,558 2,134.69% 68
2019 Q4 3,690,519 $86,285,753 +$10,150,433 2,338.07% 63
2019 Q3 3,030,091 $63,689,327 +$7,477,563 2,101.89% 57
2019 Q2 2,676,745 $54,735,507 +$671,270 2,045.13% 53
2019 Q1 2,623,653 $73,697,489 +$8,416,113 2,808.91% 64
2018 Q4 2,337,055 $57,160,517 -$411,877 2,445.81% 66
2018 Q3 2,247,761 $83,484,135 +$11,708,363 3,714.65% 68
2018 Q2 2,122,428 $44,038,752 +$5,588,999 2,074.84% 51
2018 Q1 1,710,580 $24,258,264 +$2,579,198 1,412.6% 34
2017 Q4 1,731,697 $26,254,559 +$2,439,990 1,515.26% 36
2017 Q3 1,459,156 $14,010,010 -$339,474 960.32% 27
2017 Q2 1,500,984 $12,902,009 -$2,639,238 859.48% 32
2017 Q1 1,798,934 $16,007,694 -$4,081,328 889.9% 45
2016 Q4 2,275,470 $25,256,786 -$7,709,765 1,110.11% 56
2016 Q3 2,605,006 $44,256,310 +$5,717,918 1,699% 60
2016 Q2 2,213,145 $48,158,183 -$10,186,916 2,175.96% 58
2016 Q1 2,833,006 $54,284,033 +$961,021 1,916.1% 64
2015 Q4 2,567,466 $71,964,026 +$36,452,591 2,802.67% 73
2015 Q3 1,286,850 $31,343,593 +$2,668,004 2,436.1% 45
2015 Q2 1,280,146 $29,788,794 -$1,342,477 2,327.01% 38
2015 Q1 1,300,950 $19,816,000 -$252,990 1,523.2% 20
2014 Q4 1,323,017 $17,067,000 -$360,502 1,290.3% 19
2014 Q3 1,372,532 $9,620,000 +$9,620,000 700.83% 16